Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- TBI
- Reported indication
- Rett syndrome (FDA 2023)
- First approval
- Not recorded
- Development stage
- Approved (different indication)
- ChEMBL max phase
- Not recorded
- Synonyms
- Trofinetide; Trofinetida; NNZ-2566; ACP-2566; Daybue
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 2
2 studies reported at therapy level; 2 evidence entries itemised.
RatTBI
Extraction: mesh. Machine-extracted fields require source verification.
RatTBI
Extraction: mesh. Machine-extracted fields require source verification.
